233 related articles for article (PubMed ID: 10961862)
1. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
Proost P; Menten P; Struyf S; Schutyser E; De Meester I; Van Damme J
Blood; 2000 Sep; 96(5):1674-80. PubMed ID: 10961862
[TBL] [Abstract][Full Text] [Related]
2. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils.
Struyf S; Menten P; Lenaerts JP; Put W; D'Haese A; De Clercq E; Schols D; Proost P; Van Damme J
Eur J Immunol; 2001 Jul; 31(7):2170-8. PubMed ID: 11449371
[TBL] [Abstract][Full Text] [Related]
3. The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.
Menten P; Struyf S; Schutyser E; Wuyts A; De Clercq E; Schols D; Proost P; Van Damme J
J Clin Invest; 1999 Aug; 104(4):R1-5. PubMed ID: 10449444
[TBL] [Abstract][Full Text] [Related]
4. Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction.
Proost P; Struyf S; Schols D; Opdenakker G; Sozzani S; Allavena P; Mantovani A; Augustyns K; Bal G; Haemers A; Lambeir AM; Scharpé S; Van Damme J; De Meester I
J Biol Chem; 1999 Feb; 274(7):3988-93. PubMed ID: 9933589
[TBL] [Abstract][Full Text] [Related]
5. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
[TBL] [Abstract][Full Text] [Related]
6. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
Proost P; Schutyser E; Menten P; Struyf S; Wuyts A; Opdenakker G; Detheux M; Parmentier M; Durinx C; Lambeir AM; Neyts J; Liekens S; Maudgal PC; Billiau A; Van Damme J
Blood; 2001 Dec; 98(13):3554-61. PubMed ID: 11739156
[TBL] [Abstract][Full Text] [Related]
7. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.
Proost P; De Meester I; Schols D; Struyf S; Lambeir AM; Wuyts A; Opdenakker G; De Clercq E; Scharpé S; Van Damme J
J Biol Chem; 1998 Mar; 273(13):7222-7. PubMed ID: 9516414
[TBL] [Abstract][Full Text] [Related]
8. LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity.
Nibbs RJ; Yang J; Landau NR; Mao JH; Graham GJ
J Biol Chem; 1999 Jun; 274(25):17478-83. PubMed ID: 10364178
[TBL] [Abstract][Full Text] [Related]
9. Proteolysis of macrophage inflammatory protein-1alpha isoforms LD78beta and LD78alpha by neutrophil-derived serine proteases.
Ryu OH; Choi SJ; Firatli E; Choi SW; Hart PS; Shen RF; Wang G; Wu WW; Hart TC
J Biol Chem; 2005 Apr; 280(17):17415-21. PubMed ID: 15728180
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage.
Oravecz T; Pall M; Roderiquez G; Gorrell MD; Ditto M; Nguyen NY; Boykins R; Unsworth E; Norcross MA
J Exp Med; 1997 Dec; 186(11):1865-72. PubMed ID: 9382885
[TBL] [Abstract][Full Text] [Related]
11. Enhanced anti-HIV-1 activity of CC-chemokine LD78beta, a non-allelic variant of MIP-1alpha/LD78alpha.
Xin X; Shioda T; Kato A; Liu H; Sakai Y; Nagai Y
FEBS Lett; 1999 Aug; 457(2):219-22. PubMed ID: 10471782
[TBL] [Abstract][Full Text] [Related]
12. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha.
Proost P; Struyf S; Schols D; Durinx C; Wuyts A; Lenaerts JP; De Clercq E; De Meester I; Van Damme J
FEBS Lett; 1998 Jul; 432(1-2):73-6. PubMed ID: 9710254
[TBL] [Abstract][Full Text] [Related]
13. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition.
Townson JR; Graham GJ; Landau NR; Rasala B; Nibbs RJ
J Biol Chem; 2000 Dec; 275(50):39254-61. PubMed ID: 11005816
[TBL] [Abstract][Full Text] [Related]
14. Amino-terminal processing of MIP-1beta/CCL4 by CD26/dipeptidyl-peptidase IV.
Guan E; Wang J; Norcross MA
J Cell Biochem; 2004 May; 92(1):53-64. PubMed ID: 15095403
[TBL] [Abstract][Full Text] [Related]
15. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
[TBL] [Abstract][Full Text] [Related]
16. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
Struyf S; Proost P; Schols D; De Clercq E; Opdenakker G; Lenaerts JP; Detheux M; Parmentier M; De Meester I; Scharpé S; Van Damme J
J Immunol; 1999 Apr; 162(8):4903-9. PubMed ID: 10202035
[TBL] [Abstract][Full Text] [Related]
17. Macrophage inflammatory protein-1.
Menten P; Wuyts A; Van Damme J
Cytokine Growth Factor Rev; 2002 Dec; 13(6):455-81. PubMed ID: 12401480
[TBL] [Abstract][Full Text] [Related]
18. Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication.
Miyakawa T; Obaru K; Maeda K; Harada S; Mitsuya H
J Biol Chem; 2002 Feb; 277(7):4649-55. PubMed ID: 11734558
[TBL] [Abstract][Full Text] [Related]
19. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors.
Gong X; Gong W; Kuhns DB; Ben-Baruch A; Howard OM; Wang JM
J Biol Chem; 1997 May; 272(18):11682-5. PubMed ID: 9115216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
